Live Breaking News & Updates on Amicus Therapeutics Inc
Stay updated with breaking news from Amicus therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hillsdale Investment Management Inc. lifted its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 8.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 294,300 shares of the biopharmaceutical company’s stock after purchasing an additional 23,640 shares during the period. Hillsdale […] ....
Guggenheim Upgrades Amicus Therapeutics (NASDAQ:FOLD) to Buy theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Lysosomal Storage Disease Treatment Market To Receive Overwhelming Hike In Revenues By 2027 briefingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from briefingwire.com Daily Mail and Mail on Sunday newspapers.
Amicus Therapeutics (NASDAQ:FOLD) Shares Gap Up to $9.04 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Morgan Stanley Lowers Amicus Therapeutics (NASDAQ:FOLD) Price Target to $19.00 wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.